Carfilzomib

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Teva to market cannabis inhaler; FDA makes quality metrics voluntary

This week, Phispers brings you news on J&J’s plans to acquire Actelion and Teva’s ne

DMF submissions reveal no slowdown in India & China

Every quarter, PharmaCompass compiles the latest Drug Master Files (DMFs) submitted to the US Food a